97 related articles for article (PubMed ID: 7033427)
1. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
Mang WL; Hammer C
J Med; 1981; 12(6):447-53. PubMed ID: 7033427
[TBL] [Abstract][Full Text] [Related]
2. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
[TBL] [Abstract][Full Text] [Related]
3. [Immunofluorescence of oral swabs--a new method for early recognition of recurrencies in patients with tonsillar carcinoma? (author's transl)].
Mang WL; Hammer C
Laryngol Rhinol Otol (Stuttg); 1981 Jul; 60(7):385-6. PubMed ID: 6178920
[TBL] [Abstract][Full Text] [Related]
4. [Squamous cell carcinoma of the palatine tonsils. Effect on the immune system in man].
Mang WL
Fortschr Med; 1984 Sep; 102(35):867-71. PubMed ID: 6237969
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
Górny MK; Jezewska E; Krzyśko R; Stawarz M; Zeromski J
Neoplasma; 1979; 26(6):729-36. PubMed ID: 396479
[TBL] [Abstract][Full Text] [Related]
6. Anti-squamous tumor antibodies in patients with squamous cell carcinoma.
Sofen H; O'Toole C
Cancer Res; 1978 Jan; 38(1):199-203. PubMed ID: 338144
[TBL] [Abstract][Full Text] [Related]
7. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
Stiller-Winkler R; Stark M; Idel H
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
[TBL] [Abstract][Full Text] [Related]
8. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
Nelson DS
Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
[No Abstract] [Full Text] [Related]
9. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
10. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
Cronin WJ; Dorsett BH; Ioachim HL
Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
[TBL] [Abstract][Full Text] [Related]
11. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
Kutteh WH; Doellgast GJ
J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
Dellen H; Seemayer NH
Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
[TBL] [Abstract][Full Text] [Related]
13. [Immunological studies on patients with tonsillar carcinoma: progress?].
Mang WL; Hammer C; Lersch C; Woldemar I
Strahlenther Onkol; 1987 Aug; 163(8):491-9. PubMed ID: 2957807
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.
Byers VS; Levin AS; Johnston JO; Hackett AJ
Cancer Res; 1975 Sep; 35(9):2520-31. PubMed ID: 1097109
[TBL] [Abstract][Full Text] [Related]
15. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
[No Abstract] [Full Text] [Related]
17. Failure to detect circulating IgG or IgM antibodies to basal cell carcinoma by immunofluorescence.
Blewitt RW; Aparicio SR; Burrow HM; Rowell NR; Rowell RM
Acta Derm Venereol; 1978; 58(1):82-3. PubMed ID: 75642
[TBL] [Abstract][Full Text] [Related]
18. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
19. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies in patients with cervicouterine carcinoma].
Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
